Icosavax Inc (DELISTED) (ICVX:DL)
15.31
0.00 (0.00%)
USD |
NASDAQ |
Feb 29, 16:00
Icosavax Total Assets (Quarterly): 251.30M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 251.30M |
| June 30, 2023 | 269.03M |
| March 31, 2023 | 219.67M |
| December 31, 2022 | 238.68M |
| September 30, 2022 | 243.88M |
| June 30, 2022 | 259.68M |
| Date | Value |
|---|---|
| March 31, 2022 | 276.64M |
| December 31, 2021 | 287.63M |
| September 30, 2021 | 300.82M |
| June 30, 2021 | 118.71M |
| March 31, 2021 | 125.41M |
| December 31, 2020 | 16.17M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
16.17M
Minimum
Dec 2020
300.82M
Maximum
Sep 2021
217.30M
Average
247.59M
Median
Total Assets (Quarterly) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | 1.336B |
| Immunogen Inc (DELISTED) | 822.10M |
| AbbVie Inc | 143.42B |
| Assure Holdings Corp | 5.275M |
| Harpoon Therapeutics Inc (DELISTED) | 47.58M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 18.92M |
| Shareholders Equity (Quarterly) | 232.38M |